Skip to main content

Month: February 2021

CRN® Recognizes Progress Senior Vice President, Gary Quinn, as 2021 Channel Chief

BEDFORD, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of products to develop, deploy and manage high-impact business applications, today announced that CRN®, a brand of The Channel Company, has named Gary Quinn, SVP, Core Field Organization, to its 2021 list of Channel Chiefs. The prestigious CRN® Channel Chiefs list, released annually, recognizes leading channel executives who continually demonstrate outstanding leadership, influence, innovation and growth. Quinn is responsible for Progress’ go-to-market strategy for its enterprise product portfolio.Quinn was named as one of the channel’s most influential leaders based on his proven success in leading and growing Progress’ global partner program, Progress® Accelerate™. The program supports all Progress partners with tools and resources...

Continue reading

Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules

CHATHAM, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) — TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 58,333,334 shares of common stock, par value $0.001 per share at an offering price of $1.20 per share, pursuant to a registered direct offering, priced at-the-market under Nasdaq rules. The gross proceeds of the offering will be approximately $70 million before deducting fees and other estimated offering expenses. The closing of the registered direct offering is expected to take place on or about February 9, 2021, subject to the satisfaction of customary closing conditions. A.G.P./Alliance Global Partners is acting as sole placement agent...

Continue reading

Waturu Holding A/S – new Interim CFO

Company announcement nr. 62Fredericia, February 8th 2021Waturu Holding A/S has entered into an agreement with a new Interim CFOAbout Waturu Holding A/SWaturu Holding A/S is a Greentech company, which develops innovative water technology for heating or treating water, with the focus on ensuring bacteria-free water and reducing water and energy consumption for heating hot water in properties and thus ensuring CO2 savings. Waturu Holding A/S is a major shareholder in the medical company Watgen Medical A/S and in the technology company Aquaturu A/S.Further information:CEO Toke Reedtz, cell.: +45 5188 1262, e-mail: toke@waturu.comWaturu Holding A/SSjællandsgade 327100 VejleCertified AdviserCDI GLOBAL ApS, CVR. nr. 27514278Per Vestergaard Direktør/CEO/partner Associate ProfessorVestre Havnepromenade 5, 5. sal 9000  Aalborg DenmarkT  +4598110055,...

Continue reading

Borregaard ASA: Trade subject to notification – shares for employees 2021

8 February 2021: Borregaard ASA (“Borregaard”, OSE ticker: BRG)Borregaard employees have been given the opportunity to buy shares at a discounted price. The offer is valid from 8 February up to and including 12 February 2021. The price per share will be equal to the average volume weighted market price on 12 February 2021, with a 25% discount. Under the programme, employees may buy shares for a total amount of either NOK 4 000, NOK 12 000, NOK 20 000, NOK 32 000, NOK 46 000 or NOK 60 000.The commitments made today by primary insiders to buy shares under the programme are specified in the attachment. The purchase price and the number of shares acquired in this way by primary insiders, as well as their updated shareholdings, will be notified to the Stock Exchange immediately after the determination of the purchase price.Contact:Lotte Kvinlaug,...

Continue reading

Nexstim Plc: Invitation to the Extraordinary General Meeting

Company announcement, inside information, Helsinki, 8 February 2021 at 5.35 PM (EET)Nexstim Plc: Invitation to the Extraordinary General Meeting  Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) invites shareholders to the Extraordinary General Meeting of the Company to decide on authorizations for the Board of Directors to decide on share issues and issuances of option rights and special rights to shares. The Extraordinary General Meeting will be held on Monday, March 1, 2021 commencing at 1 PM (EET) at the Nexstim Headquarters, Elimäenkatu 9 B (inner court), 4th floor, 00510 Helsinki. The reception of persons who have registered for the meeting will commence at 12.30 PM (EET). Since the risk of getting infected by coronavirus is still significant, all shareholders are strongly encouraged to exercise their voting rights by...

Continue reading

Nexstim Oyj: Kutsu ylimääräiseen yhtiökokoukseen

Nexstim Oyj: Kutsu ylimääräiseen yhtiökokoukseenYhtiötiedote, sisäpiiritieto, Helsinki, 8.2.2021 klo 17.35 (EET)Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (“Nexstim” tai “yhtiö”) kutsuu osakkeenomistajat ylimääräiseen yhtiökokoukseen päättämään hallitukselle annettavista valtuutuksista osakeanteihin sekä optio- ja erityisten oikeuksien antamiseen. Yhtiökokous pidetään maanantaina 1.3.2021 klo 13.00 (EET) alkaen Nexstimin pääkonttorilla, Elimäenkatu 9 B (sisäpiha), 4 krs , 00510 Helsinki. Kokoukseen ilmoittautuneiden vastaanottaminen alkaa kello 12.30. Koska koronavirukseen sairastumisen riski on edelleen merkittävä, kaikkia osakkeenomistajia kannustetaan vahvasti käyttämään äänioikeuttaan valtakirjalla, joka voidaan osoittaa yhtiön lakiasiainjohtajalle. Lisätietoja ja ohjeita valtakirjan antamisesta on saatavilla yhtiön...

Continue reading

Nexstim Abp: Ny kallelse till extra bolagstämma

Företagsmeddelande, insiderinformation, Helsingfors den 8 februari 2021 kl. 17.35 (EET)Nexstim Abp: Ny kallelse till extra bolagstämmaNexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolag”) bjuder in aktieägarna till extra bolagstämma för att fatta beslut om styrelsens bemyndigande att emittera nya aktier samt optionsrättar och andra speciella rättigheter till aktierna. Bolagsstämman hålls mondagen den 1 mars 2021 kl. 13.00 (EET) på Nexstim Huvudkontor på Elimäenkatu 9 B (innergård), 4:e våningen, 00510 Helsingfors, Finland. Mottagandet av personer som har registrerat sig för stämman inleds klockan 12.30 (EET). På grund av den ännu väsentliga risken för insjuknande i coronavirus, uppmuntras alla aktieägare starkt att utöva sin rösträtt genom fullmakt, vilken kan riktas till bolagets chefsjurist. Ytterligare information och instruktioner...

Continue reading

Construction contract in Lithuania (production building in Kaunas district)

On 8 February 2021, UAB Merko statyba, part of AS Merko Ehitus group, and UAB Continental Automotive Lithuania entered into a contract to perform construction works of a production building in Kaunas district, Lithuania.  The contract value is over EUR 10 million, plus value added tax. The project is scheduled to be completed in first half of 2022.  UAB Merko statyba (merko.lt) is Lithuanian construction company, which offers construction services in the fields of general construction and residential construction.  Additional information: UAB Merko Statyba, Construction Director Mr. Jaanus Rästas, phone: +370 6875 0680.  Priit RoosimägiHead of Group Finance UnitAS Merko Ehitus+372 650 1250priit.roosimagi@merko.eeAS Merko Ehitus (group.merko.ee) group consists of AS Merko Ehitus Eesti in Estonia, SIA Merks in Latvia, UAB Merko Statyba...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.